Company
United StatesPublic company, NYSE: MDTMedtronic, Inc. (NYSE: MDT), Fridley, MN – FDA Inspections
Inspection records and compliance data for Medtronic, Inc. in Fridley, Minnesota. 1 FDA inspection on record, 1 Form 483, last inspected December 10, 2025. Publicly traded as NYSE: MDT.
Company Profile
This profile covers Medtronic, Inc. based in Fridley, Minnesota, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
Inspected December 10, 2025.
Most cited issue areas
- Establish reliability of supplier's C of A1 inspection
- Sterility/pyrogen-free testing1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 10, 2025 | VAI | Human Drugs · Drug Quality Assurance | 1294794 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
CHRI Laboratories, Inc.
Freethink Technologies, Inc.
Pharmetric Laboratory LLC
Daane Labs
PathoQuest, Inc.
Accelerated Analytical Laboratories Inc.
International Contract Labs DBA Analytical Resource Laboratories LLC (St. Petersburg, FL)
Delta Labs of South Florida Corp
Infinity Labs Sd, Inc
Element Materials Technology Bend, LLC
Company Information
Name
Medtronic, Inc.
Stock ticker
MDT
Exchange
NYSE
Share price
$100.98
Market cap
$129.2B
Price as of
November 13, 2026
FEI Number
3015544746
Address
7000 Central Ave NE, Fridley, Minnesota, United States
Country
United States
ID: 4a096e52-76ca-4b08-86e5-c8ce20bd6949